Figures & data
Table 1 Description of the females cancer breast patients by clinic pathological parameters (n = 50).
Figure 1 Gel electrophoresis of RT-PCR products of Mammoglobin (108 bp), Mucin-1 (238 bp) and β-actin (607 bp).
Table 2 Changes in the percentage expression of all parameters; before surgery, 2 weeks after surgery, & after 6 cycles of treatment.
Figure 2 ROC curve of Mammoglobin, Mucin 1 and CA 15.3 as diagnostic markers for breast cancer before surgery.
Table 3 Correlations between Mammoglobin and Mucin-1, 2 weeks after surgery and after 6 cycles of chemotherapy with various clinical parameters.
Table 4 The relative risk for breast cancer metastasis according to the biochemical parameters, 2 weeks after surgery.
Table 5 The relative risk for breast cancer metastasis according to the biochemical parameters, after 6 cycles of treatment.
Figure 3 Metastasis free survival in breast cancer females negative and positive to Mucin-1, 2 weeks after surgery.
Figure 4 Metastasis free survival in breast cancer females negative and positive to Mammoglobin, after 6 cycles of treatment.
Figure 5 Metastasis free survival in breast cancer females negative and positive to Mucin-1, after 6 cycles of treatment.
Figure 6 ROC curve for Mammoglobin, Mucin-1 and CA 15.3 as prognostic markers for metastasis in females with breast cancer after 6 cycles of chemotherapy.
